Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Jun 16, 2014 3:54pm
277 Views
Post# 22664476

$2.3 M private placement

$2.3 M private placementHi folks.

Sanfran, I just re-read the responses to the questions you put to management and now that I've calmed down I feel much more positive about their responses although I would like to see more commitment from them.

Add to that the $2.3MM private placement with a four month hold period and the fact that directors and management have ponied up to the bar with their own cash it suggests to me that something good is in the works. They could gain big by the end of the 4 month hold period.

The fact that NGN went in for 1,230,796 shares to now hold 9.3% says to me NGN believes in the findings to date and that rvx-208 has high potential.

Perhaps things will begin to move at a better pace.

There was a good article posted in Investor Village (not sure but someone may have posted it here as well) related to low HDL and diabetes type 2.

More hopeful today and slightly less frustrated.
Toinv


Bullboard Posts